|
|
Volumn 19, Issue 4, 2013, Pages
|
|
Infliximab treatment induces levels of the active azathioprine metabolite TGTP in Crohn's disease.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
6-THIOGUANOSINE 5'-TRIPHOSPHATE;
AZATHIOPRINE;
DRUG DERIVATIVE;
GASTROINTESTINAL AGENT;
GUANOSINE TRIPHOSPHATE;
IMMUNOSUPPRESSIVE AGENT;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
NUCLEOTIDE;
THIOGUANOSINE TRIPHOSPHATE;
TUMOR NECROSIS FACTOR ALPHA;
APOPTOSIS;
CROHN DISEASE;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG EFFECT;
HUMAN;
LETTER;
METABOLISM;
PROGNOSIS;
ANTIBODIES, MONOCLONAL;
APOPTOSIS;
AZATHIOPRINE;
CROHN DISEASE;
DRUG THERAPY, COMBINATION;
GASTROINTESTINAL AGENTS;
GUANOSINE TRIPHOSPHATE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
PROGNOSIS;
THIONUCLEOTIDES;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 85028121681
PISSN: None
EISSN: 15364844
Source Type: None
DOI: 10.1002/ibd.22998 Document Type: Letter |
|
Times cited : (10)
|
|
References (0)
|
